Company news
Getein Biotech, Inc. Class A (SSE:603387) news
Getein Biotech, Inc. Class A news releases on 6ix. Latest, Sep 16, 2026: "Getein Biotech, Inc."Announcement on Outline of the 2026 Semi-annual Online…
Press releases & updates
"Getein Biotech, Inc."Announcement on Outline of the 2026 Semi-annual Online Performance Briefing
September 15, 2026
"Getein Biotech, Inc."Announcement on Adjustment of Upper Limit of Repurchase Price Following Implementation of Dividend Distribution for the First Half of 2026
September 11, 2026
"Getein Biotech, Inc."Announcement on Obtaining a Commitment Letter for a Special Loan for Share Repurchase from a Financial Institution
August 31, 2026
"Getein Biotech, Inc."Announcement on Resolutions of the 14th Meeting of the 4th Board of Directors
August 26, 2026
"Getein Biotech, Inc."Announcement on Progress in Repurchasing Shares through Call Auction
August 3, 2026
"Getein Biotech, Inc."Announcement on the Progress of Implementing the "Settlement Agreement" and Transferring Equity Interests in a Controlled Subsidiary
July 16, 2026
"Getein Biotech, Inc"Announcement on Expected Increase in Semi-annual Performance for 2026
July 14, 2026
"Getein Biotech, Inc"Announcement on the Shareholdings of the Top Ten Shareholders and the Top Ten Holders of Unrestricted Shares Prior to the Share Repurchase
July 8, 2026
"Getein Biotech, Inc"Announcement on the Initial Repurchase of Shares through Call Auction
July 7, 2026
Announcement on Implementation of Dividend Distribution for 2025
June 11, 2026
Announcement on Outline of the Online Performance Briefing for 2025 and Q1 2026
May 27, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 22, 2026
Announcement on Using Self-owned Idle Funds for Investment and Wealth Management
April 29, 2026
and Transfer of Equity in the Holding Subsidiary
April 24, 2026
Announcement on Appointing the Secretary of the Board of Directors
April 13, 2026
Announcement on Adjustment of Partial Members of the Special Committee of the Board of Directors
April 10, 2026
Announcement on Resignation of the Securities Affairs Representative
March 27, 2026
Announcement on Resignation of Secretary of Board of Directors
March 20, 2026
Announcement on Abnormal Fluctuations in Stock Trading
March 18, 2026
Announcement on Outline of the Q3 2025 Online Performance Briefing
November 21, 2025
Report for Q3 2025
October 30, 2025
Announcement on Completing Industrial and Commercial Change Registration and Filing and Obtaining the Business License
September 29, 2025
Announcement on Progress in Litigation Involving the Company
September 18, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
September 15, 2025
Announcement on Outline of the 2025 Semi-annual Performance Online Briefing
September 10, 2025
Announcement on Implementation of Semi-annual Dividend Distribution for 2025
September 8, 2025
Announcement on Resolutions of the 7th Meeting of the 4th Board of Directors
August 29, 2025
Announcement on Result of Shareholding Reduction by Shareholder
August 15, 2025
Announcement on Progress of Litigation Involving the Company
July 22, 2025
Announcement on Investment in Construction of an Intelligent Production and R&D Base
July 4, 2025
Announcement on Implementation of Dividend Distribution for 2024
June 10, 2025
Announcement on Outline of the Online 2024 Annual and Q1 2025 Performance Briefing
May 27, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 22, 2025
Announcement on Share Reduction Plan for Shareholders
May 14, 2025
Announcement on the Interim Dividend Distribution Arrangement in 2025
May 13, 2025
Announcement on Changes in Accounting Policies
April 29, 2025
Announcement on Result of Litigation Involving the Company
February 26, 2025
Announcement on Litigation Involving the Company
December 24, 2024
Announcement on Outline of the Q3 2024 Online Performance Briefing
November 12, 2024
Announcement on Resolutions of the 4th Meeting of the 4th Board of Supervisors
October 30, 2024
Announcement on Termination of Listing on National Equities Exchange and Quotations by Holding Subsidiary Wuhan King Diagnostic Technology Co., Ltd.
October 24, 2024
Announcement on Progress of the Company's Involvement in Litigation
October 18, 2024
Announcement on the Convening of Online Briefing on 2024 Semi-annual Performance
September 12, 2024
Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate for Relevant Product
September 11, 2024
Announcement on Implementation of Semi-annual Dividend Distribution in 2024
September 10, 2024
Announcement on Resolutions of the 3rd Meeting of the 4th Board of Directors
August 30, 2024